Lu, C <br/><br/>
Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.  [electronic resource] 

 -  Leukemia research  Mar 2006 
 - 296-302 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2005.06.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--biosynthesis<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--pharmacology<br/>Antigens, CD34--biosynthesis<br/>Antineoplastic Agents--immunology<br/>Apoptosis--drug effects<br/>Biomarkers, Tumor--biosynthesis<br/>Blast Crisis--drug therapy<br/>Cell Line, Tumor<br/>Chromosome Aberrations<br/>Clinical Trials as Topic<br/>Cytarabine--pharmacology<br/>Daunorubicin--pharmacology<br/>Drug Evaluation, Preclinical<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Female<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Pilot Projects<br/>Receptors, Cytokine--metabolism<br/>Stem Cell Factor--antagonists & inhibitors<br/>Treatment Outcome<br/>bcl-2-Associated X Protein--biosynthesis